Free Project Management Templates

This schedule outlines the clinical development of an experimental fictitious drug, focusing on the various testing groups.  This schedule may typically be used by research and development groups, who are primarily responsible for post production work.  The schedule also consolidates other segments of the development process, tracks cost by phase, provides an FDA Compliance Milestone column, and indicates which pieces of the schedule should be cross referenced with other schedules.

This schedule illustrates a timeline for the clinical study of a potential generic drug. Major milestones and phases associated with the clinical study include: Contacting CROs for Pilot Study Bids, Final Clinical Study Report, and submission of the results to the FDA.

This schedule organizes the final testing phases and manufacturing process of a fictitious drug in all its forms of dissemination (inhaler, capsule and injection).  The drug will ultimately go into production through a contract manufacturer. The schedule presents the importance of the reviewing the work that needs to be done to selecting an appropriate facility, and not interfere with the final stages of FDA approval.

This Schedule outlines the Preclinical phases of a fictitious drug, and the various stages of testing through various on both murine and primate populations.  Burn Rates cost analysis are provided in this schedule as both columnar data and across the timeline as summary graph.